CytosorbentsCTSO
13F holders, Q2 2025 (June 30)45holders −4
3new positions
7sold out
1famous investor
$1.26avg. 13F price*
At the end of Q2 2025, 45 institutions reported holding Cytosorbents Corp. (CTSO) in their 13F filings, down 4 from Q1 2025. 3 opened new positions and 7 sold out. The largest holders were Avenir Corp. ($6.5M), Skylands Capital, LLC ($3.3M) and Vanguard Group Inc. ($2.7M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cytosorbents Corp.
- CUSIP
- 23283X206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $170K |
| Exits | 7 | $468K |
All 13F filers, Q1 2025 → Q2 2025: 743,655 shares bought and 1,241,908 shares sold, net −498,253 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Avenir Corp. | 0.67% | Add +0.3% | 5,058,537 | $6.5M |
| Skylands Capital, LLC | 0.49% | Reduce -12.8% | 2,616,715 | $3.3M |
| Vanguard Group Inc. | 0.00% | Add +9.0% | 2,124,759 | $2.7M |
| Neuberger Berman Group LLC | 0.00% | Reduce -5.2% | 1,591,689 | $2.0M |
| CM Management, LLC | 1.46% | Add +31.0% | 1,250,000 | $1.6M |
| BlackRock, Inc. | 0.00% | Add +18.9% | 745,613 | $954K |
| Geode Capital Management, LLC | 0.00% | Reduce -2.0% | 601,451 | $770K |
| Sargent Investment Group, LLC | 0.09% | Reduce -9.4% | 746,200 | $673K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 172,649 | $221K |
| State Street Corp. | 0.00% | No change | 159,293 | $204K |
| Susquehanna International Group, LLP | 0.00% | New | 131,853 | $169K |
| Osaic Holdings, Inc. | 0.00% | Reduce -20.4% | 130,419 | $167K |
| UBS Group AG | 0.00% | Add +6.2% | 122,332 | $157K |
| Renaissance Technologies | 0.00% | Reduce -48.2% | 116,639 | $149K |
| Raymond James Financial Inc. | 0.00% | Reduce -1.6% | 108,589 | $139K |
| Morgan Stanley | 0.00% | Reduce -0.3% | 105,410 | $135K |
| NWF Advisory Services Inc. | 0.02% | No change | 104,139 | $133K |
| Northern Trust Corp. | 0.00% | No change | 91,560 | $117K |
| Key Client Fiduciary Advisors, LLC | 0.04% | No change | 78,457 | $100K |
| Kestra Advisory Services, LLC | 0.00% | No change | 70,880 | $91K |
| Stifel Financial Corp. | 0.00% | No change | 48,000 | $61K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -25.3% | 46,796 | $60K |
| Bank of America Corp. | 0.00% | Reduce -11.2% | 39,074 | $50K |
| EP Wealth Advisors, LLC | 0.00% | No change | 28,000 | $36K |
| Compound Planning, Inc. | 0.00% | Reduce -0.7% | 27,443 | $35K |
| Creative Planning | 0.00% | Reduce -4.3% | 22,115 | $28K |
| Seelaus Asset Management LLC | 0.02% | No change | 18,300 | $23K |
| Sei Investments Co. | 0.00% | Reduce -32.5% | 17,930 | $23K |
| Merit Financial Group, LLC | 0.00% | Add +1.4% | 15,297 | $20K |
| Country Club Bank | 0.00% | No change | 15,225 | $19K |
| Squarepoint Ops LLC | 0.00% | Reduce -71.1% | 11,712 | $15K |
| Chicago Partners Investment Group LLC | 0.00% | Reduce -8.6% | 12,281 | $13K |
| Comerica Bank | 0.00% | Reduce -9.3% | 3,000 | $4K |
| N.E.W. Advisory Services LLC | 0.00% | No change | 2,720 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -72.0% | 1,538 | $2K |
| Royal Bank of Canada | 0.00% | New | 800 | $1K |
| Wells Fargo & Company | 0.00% | Add +192.0% | 730 | $934 |
| JPMorgan Chase & Co. | 0.00% | Reduce -23.3% | 372 | $476 |
| Your Advocates Ltd., LLP | 0.00% | No change | 250 | $320 |
| MAI Capital Management | 0.00% | No change | 233 | $299 |
| SBI Securities Co., Ltd. | 0.00% | No change | 100 | $128 |
| Medallion Wealth Advisors, LLC | 0.00% | No change | 45 | $58 |
| PNC Financial Services Group, Inc. | 0.00% | No change | 31 | $40 |
| BNP Paribas Financial Markets | 0.00% | Add +566.7% | 20 | $26 |
| Simplex Trading, LLC | 0.00% | New | 100 | $0 |
"% of holder's portfolio" is CTSO's weight in each manager's 13F, not the share of Cytosorbents Corp. the manager owns.